1. Home
  2. News
  3. Kexing Biopharm Co., Ltd.
  4. Shareholders' Inquiry Transfer Plan
More Kexing Biopharm Co., Ltd. news
Kexing Biopharm Co., Ltd.SSE: 688136

Shareholders' Inquiry Transfer Plan

Nov 15, 2025 · Issued by Kexing Biopharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Nov 15, 2025 · 4 pages · Chinese

On 6ix: 6ix.com/news/shareholders-inquiry-transfer-plan-6

Kexing Biopharm Co., Ltd. on 6ix

Earlier from Kexing Biopharm

  • Announcement on Cancellation of Special Settlement Accounts for Some Raised Fund Financial ProductsNov 13, 2025
  • Announcement on Convening the Q3 2025 Performance BriefingNov 11, 2025
  • Kexing Biopharm Showcases Global Strategy and Partnership Opportunities at CPHI Frankfurt 2025Oct 31, 2025
  • Report for Q3 2025Oct 30, 2025
  • Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Oct 18, 2025

Later from Kexing Biopharm

  • Indicative Announcement on Pricing for Shareholders' Inquiry-based TransferNov 18, 2025
  • Indicative Announcement on Report on Results of Shareholders' Inquiry Transfer and Equity Change of Shareholders with Over 5% Shares Reaching 5% Integer MultipleNov 21, 2025
  • Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Ophthalmic Preparation GB10 InjectionDec 9, 2025
  • Announcement on Renewing Engagement of Accounting FirmDec 16, 2025
  • Announcement on Estimated Amount of Daily Related Transactions in 2026Jan 1
All Kexing Biopharm news releases↗

Follow Kexing Biopharm into a list and get an email when it puts out news.

Follow Kexing Biopharm
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer